Company Filing History:
Years Active: 1996
Title: Arieh Gutman: Innovator in Pharmaceutical Chemistry
Introduction
Arieh Gutman is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Gutman holds a patent for monofluorinated derivatives of N-propargyl-1-aminoindan. This patent details their use as selective inhibitors of monoamine oxidase (MAO). The invention includes several processes for the preparation of these novel compounds. Additionally, it introduces 1-aminoindans monofluorinated in the phenyl ring, which serve as intermediates in the preparation of the corresponding novel N-propargyl derivatives.
Career Highlights
Arieh Gutman is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to contribute to the advancement of drug development and innovation in the pharmaceutical sector.
Collaborations
Throughout his career, Gutman has collaborated with esteemed colleagues, including Jeff Sterling and Ruth Levy. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Arieh Gutman is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His innovative contributions continue to impact the field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.